Core Viewpoint - Microchip (MCHP) shares have underperformed significantly in 2023, with a decline of 32.8%, compared to the broader semiconductor industry and technology sector [1] Group 1: Company Performance - MCHP shares have lagged behind industry peers such as Analog Devices (ADI), Semtec Corporation (SMTC), and MACOM Technology Solutions (MTSI), which have seen declines of 18.7%, 26.6%, and 58.8% respectively [2][1] - The company is facing challenges due to broad-based weakness across multiple product lines, including microcontrollers, analog, and FPGAs, and is navigating a significant inventory correction post-COVID [3] Group 2: Product Developments and Strategic Focus - Microchip has announced advancements in its product portfolio, including a radiation-hardened power MOSFET family that meets JANSF qualification for space applications, enhancing its position in the defense and aerospace sectors [4] - The launch of the BR235 and BR235D series of power relays designed for mission-critical applications reinforces the company's commitment to military and space sectors [5] - The PolarFire SoC FPGAs have earned AEC-Q100 qualification for automotive applications, marking a significant step in Microchip's automotive strategy [6] - The MCP16701 PMIC is aimed at high-performance applications such as AI and data centers, addressing the demand for advanced power management solutions [7] - Microchip's diverse and expanding portfolio is positioned to capitalize on high-growth industries, including automotive, aerospace, and power management, with innovative product developments being a key catalyst [8] Group 3: Financial Outlook - For the fourth quarter of fiscal 2025, Microchip's non-GAAP earnings per share are expected to be between 5 cents and 15 cents, with a Zacks Consensus Estimate of 10 cents per share, indicating an 82.5% year-over-year decline [9] - Projected revenues for the same quarter are between 1 billion, with a Zacks Consensus Estimate of $961.07 million, suggesting a decline of 27.51% year over year [9]
Can MCHP's Expanding Portfolio Help the Stock Recover in 2025?